Retrospective cohort study shows low-dose aspirin does not reduce hypertensive disorders risk in SLE pregnancies, indicating need for risk assessment.
LDA did not significantly reduce the incidence of HDP in women with SLE. This lack of effect may reflect the low event rate in a well-controlled cohort. These findings underscore the need for individualized risk assessment and careful monitoring, beyond reliance on LDA alone, in the management of pregnancies with SLE.
No takes yet. Share an insight, caveat, or question.
Kohno et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: